ViroLogic to Present at the Deutsche Bank Securities 30th Annual Health Care Conference on May 4, 2005

ViroLogic to Present at the Deutsche Bank Securities 30th Annual
Health Care Conference on May 4, 2005 


SOUTH SAN FRANCISCO, Calif., April 22  /PRNewswire-FirstCall/ -- ViroLogic,
Inc. (NASDAQ:VLGC) announced today that William D. Young, CEO and Chairman, is
scheduled to present a corporate overview at the Deutsche Bank Securities 30th
Annual Health Care Conference on Wednesday, May 4, 2005 at 8:00 a.m. The event
will be held at the Hyatt Regency Hotel in Baltimore, Maryland from May 2-4,
2005.

To access the live audio broadcast or the subsequent archived recording log on
to http://www.virologic.com/ and go to the investor relations section. The
archived version of the webcast will be available online for one month.

About ViroLogic

ViroLogic is a biotechnology company advancing individualized medicine by
discovering, developing and marketing innovative products to guide and improve
treatment of serious infectious diseases and cancer. The Company's products are
designed to help doctors optimize treatment regimens for their patients that
lead to better outcomes and reduced costs. The Company's technology is also
being used by numerous biopharmaceutical companies to develop new and improved
antiviral therapeutics and vaccines as well as targeted cancer therapeutics.
More information about the Company and its technology can be found on its web
site at http://www.virologic.com/. 

DATASOURCE: ViroLogic, Inc.



CONTACT:  Alfred Merriweather, Vice President and CFO of ViroLogic, Inc.,

[phone]; or Carolyn Bumgardner Wang of WeissComm Partners,

[phone], or , for ViroLogic, Inc.



Web site:  http://www.virologic.com/ 

Copyright